2024-07-05 | Company
Sustainability report 2023
Our ability to achieve business success and deliver long-term customer value depends on our systematic and strategic efforts to monitor and enhance our global sustainability impact.
2024-07-05 | Company
Our ability to achieve business success and deliver long-term customer value depends on our systematic and strategic efforts to monitor and enhance our global sustainability impact.
2023-12-21 | Company
Sever Pharma Solutions, a leading Contract Development and Manufacturing Organization (CDMO) specializing in controlled release systems for highly potent drugs is pleased to announce the successful attainment of the Drug Enforcement Administration (DEA) license for its site in Putnam, CT.
2023-12-19 | Company
During 2022, we initiated the expansion of the R&D capacity at our US site in Putnam and increased our capabilities with a new line for aseptic fill and finish. Read the full company report.
2023-10-18 | Company
We pleased to announce the approval by the Swedish Health authorities of its state-of-the-art aseptic filling line for syringes, specifically designed for high potent injectable drugs, at its Malmo site.
2023-10-11 | Company
We are happy to announce that Kristian Ahlgren has been appointed as Director of Supply Chain Management.
2023-09-21 | Company
[Putnam, CT, USA - Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI) manufacturing suites.
2023-09-13 | Company
Tony Listro, Vice President of Technology and Site Lead for SPS’s North American site in Putnam, CT, discusses the company’s recent focus areas and current expansion plans.
2023-07-07 | Company
Sustainability is front and center for a company of our kind. Subsequently, Sever Pharma Solutions is entirely focused on human health and well-being. Read the full sustainability report.